Status:
TERMINATED
Binocular Vision in Monocular Pseudophakia
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Oxford University Hospitals NHS Trust
Conditions:
Cataract
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Following cataract surgery, an intraocular lens (IOL) is implanted in the eye. The majority of people develop an operable cataract when they are over the age of 50. Occasionally people under 50 years ...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study.
- Male or female, aged 18 - 45.
- Cataract operation required in one eye only, either due to the presence of cataract affecting visual function, or in combination with surgery which is likely to cause visually significant cataract.
- Expected visual improvement in operable eye of at least 6/12.
- Fellow eye with a VA of at least 6/9.
- Astigmatism of 1.0D or less.
- Target of emmetropia in the operated eye.
- Intact posterior capsule with planned implantation into the capsular bag.
- IOL power required 10 - 30D.
Exclusion
- Pre-existing amblyopia or squint.
- Significant diabetic retinopathy.
- Macular off retinal detachment with metamorphopsia or poor visual prognosis.
- Other macula or ophthalmic pathology affecting macula function resulting in poor visual prognosis.
- Pregnancy, lactating or planned pregnancy during the study period.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01872000
Start Date
April 1 2013
End Date
October 1 2018
Last Update
June 13 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford University Hospitals NHS Trust
Oxford, Oxfordshire, United Kingdom, OX3 9DU
2
Stoke Mandeville Hospital
Aylesbury, United Kingdom